Karo Bio To Acquire Novalon

is acquiring the American biotechnology company based in Durham, North Carolina through a non- cash issue.

“The acquisition of Novalon will strengthen Karo Bio’s technology base for the development of new drug substances that act upon nuclear receptors, which will make it possible to start several new projects and partnerships.

It also provides Karo Bio with an opportunity to develop research programs in new areas such as the identification of therapeutics that act upon new pharmaceutical targets derived from discoveries coming from genomics research.

With operations in Europe and the United States, Karo Bio will have better exposure to future collaborative partners and institutional investors,” says Mr. Per- Olof Martensson, President and CEO of Karo Bio.

“By joining with Karo Bio, Novalon is gaining an opportunity to fully exploit the technology platform the company has developed.

The merging of our technologies and research programs will greatly accelerate the pace and scope of our joint drug development,” says Dr. Dana Fowlkes, Chairman, CEO and founder of Novalon.

The new Karo Bio will have collaborative agreements with the leading life science companies , , Inc., Bayer AG, Ares-, . and Research Foundation.

The joint technology platforms encompass both nuclear receptors and genomics.

The deal is conditional on Karo Bio‘s shareholders approving a directed new share issue at the Annual General Meeting on 26 April.

In addition, at that meeting and as a first step towards a stock exchange listing abroad, the company shall propose a new share issue with a value of around SEK 200 million directed to institutional investors.

Karo Bio is a research-based pharmaceutical company developing tissue-selective drug substances that act via nuclear receptors for the treatment of common diseases such as diabetes, obesity, elevated cholesterol, inflammatory disorders, cancer, cardiovascular diseases and certain women’s health problems.

Development takes place in collaboration with international pharmaceutical companies and leading universities.

Procure Dragon Pharmaceutical on the Internet

Nolvadex - Bulk Price

Administration: Oral
Primary Component: Tamoxifen Citrate
Manufacturer: Dragon Pharma Labs
Pack: 10 x 100 pills (20 mg/tab)
Price: 10 x $40.00

Clenbuterol - Discount Price

Administration: Oral
Prime Ingredient: Clenbuterol Hydrochloride
Produced by: Dragon Pharma
Package: 30 x 100 pills (40 mcg/tablet)
Price: 30 x $20

Cypionat 250 - Bulk Price

Administration: Injection
Main Constituent: Testosterone Cypionate
Produced by: Dragon Pharma LLC
Package: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00

Trenbolone 200

Injectable Anabolic Steroid
Primary Chemical Name: Trenbolone Enanthate
Produced by: Dragon Pharma LLC
Unit: 1 X 10 ml (200 mg/ml)

Enantat 250 - Cheap Price

Administration: Injection
Main Constituent: Testosterone Enanthate
Branded by: Dragon Pharma Labs
Pack: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Clenbuterol - Cheap Price

Administration: Oral
Active Ingredient: Clenbuterol Hydrochloride
Produced by: Dragon Pharma Labs
Amount: 20 x 100 tabs (40 mcg/tab)
Price: 20 x $25

Winstrol Depot

Injectable Anabolic Steroid
Basal Constituent: Stanozolol
Produced by: Dragon Pharmaceuticals
Package: 1 X 10 ml (50 mg/ml)

EQ 300

Base Ingredient: Boldenone Undecylenate
Producer: Dragon Pharmaceuticals
Amount: 10 x 10 mL vial (300 mg/mL)

EQ 200 / Test E 200

Primary Constituent: Boldenone Undecylenate, Testosterone Enanthate
Producer: Dragon Pharma
Pack: 10 mL vial (400 mg/mL)

Cut Mix 150

Basal Chemical Name: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Producer: Dragon Pharma LLC
Pack: 10 x 10 mL vial (150 mg/mL)

Cut Long 300

Prime Constituent: Drostanolone Enanthate, Testosterone Enanthate
Trenbolone Enanthate
Branded by: Dragon Pharma LLC
Package: 10 mL vial (300 mg/mL)

Deca 500

Main Constituent: Nandrolone Decanoate
Made by: Dragon Pharmaceutical
Unit: 10 mL vial (500 mg/mL)